Acupuncture for Adverse Effects of Interferon Therapy for Hepatitis C Infection

被引:2
|
作者
Miller, Diane [1 ]
Taylor-Young, Patricia [1 ]
机构
[1] Oregon Hlth & Sci Univ, Portland VA Med Ctr, Portland, OR 97201 USA
关键词
Acupuncture; Hepatitis C; Interferon Therapy;
D O I
10.1089/acu.2010.0740
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Background: Interferon, the recommended treatment for hepatitis C infection, is sometimes poorly tolerated due to its adverse effect profile. Many patients report flu-like symptoms, joint and muscle pains, and intestinal abnormalities often severe enough to cause patients to abandon treatment. Acupuncture has been shown to be an effective treatment for such constitutional symptoms. Objective: To determine if acupuncture could reduce adverse effects in patients receiving interferon therapy for hepatitis C infection. Design, Setting, and Patients: A weekly group acupuncture clinic was created for 6 months (May-October 2009) at the Portland VA Medical Center in Portland, Oregon. All patients receiving interferon therapy for hepatitis C were offered weekly group acupuncture to assess its effect on typical adverse effects associated with interferon. Intervention: Voluntary, anonymous survey packets were distributed to patients before each acupuncture session so they could rate the severity (before vs after acupuncture) of their symptoms of fatigue, muscle aches, irritability, and nausea on a 0-5 Likert scale. Acupuncture consisted of mostly auricular acupuncture points unilaterally (in the style of the Five Needle protocol), and possible scalp or hand command points as indicated by pulse diagnosis. Main Outcome Measure: Fourteen patients completed 39 preacupuncture and postacupuncture session evaluations of their symptoms. Results: Patients described significant reductions in fatigue, muscle aches, irritability, and nausea during their acupuncture treatments. Severity of fatigue decreased 25.7% (P =.01), muscle aches decreased 33.7% (P =.003), irritability decreased 39.5% (P<. 001), and nausea decreased 16.8% (P =.045). Conclusions: Acupuncture appears to offer significant benefits to patients treated with interferon for hepatitis C infection in decreasing adverse effect symptoms of muscle aches, fatigue, irritability, and nausea. Further research is needed to identify the cost-benefit ratio, patient response to treatment, and adherence rates to therapy.
引用
收藏
页码:117 / 120
页数:4
相关论文
共 50 条
  • [21] Hematologic adverse effects and efficacy monitoring in chronic Hepatitis C patients treated with interferon and ribavirin combination therapy
    Rafique, Ghazala
    Bukhsh, Allah
    Gul, Asif
    Khiljee, Sonia
    Ashraf, Muhammad
    Omer, Muhammad Ovais
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 30 (01) : 11 - 16
  • [22] Ophthalmological side effects of interferon therapy of chronic hepatitis C
    Medhat, Eman
    Esmat, Gamal
    Hamza, Eman
    Aziz, Amr Abdel
    Fathalah, Waleed Fouad
    Darweesh, Samar Kamal
    Zakaria, Zeinab
    Mostafa, Sameh
    HEPATOBILIARY SURGERY AND NUTRITION, 2016, 5 (03) : 209 - 216
  • [23] Immunodisregulation in hepatitis C:: Effects of interferon-α therapy.
    Lukic, ML
    Ukabam, S
    Gohar, HH
    Shahin, A
    HEPATOLOGY, 1999, 30 (04) : 602A - 602A
  • [24] Hepatitis C virus infection in kidney transplantation and a pilot study of the effects of interferon-alpha therapy
    Hanafusa, T
    Ichikawa, Y
    Yazawa, K
    Kishikawa, H
    Fukunishi, T
    Kanai, T
    Shinji, Y
    Nagano, S
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (01) : 122 - 124
  • [25] Adverse effects in hepatitis B and C treated with interferon. Any difference?
    Marinho, R
    Serejo, F
    Raimundo, M
    Gloria, H
    Ramalho, F
    Velosa, J
    Moura, MC
    HEPATOLOGY, 1996, 24 (04) : 1668 - 1668
  • [26] Comparison of adverse effects related to pegylated interferon-based therapy for patients with chronic hepatitis B and chronic hepatitis C in Taiwan
    Jeng-Fu Yang
    Yi-Hui Kao
    Chia-Yen Dai
    Jee-Fu Huang
    Ming-Yen Hsieh
    Zu-Yau Lin
    Shinn-Cherng Chen
    Ming-Yuh Hsieh
    Liang-Yen Wang
    Wan-Long Chuang
    Ming-Lung Yu
    Hepatology International, 2010, 4 : 732 - 740
  • [27] Comparison of adverse effects related to pegylated interferon-based therapy for patients with chronic hepatitis B and chronic hepatitis C in Taiwan
    Yang, Jeng-Fu
    Kao, Yi-Hui
    Dai, Chia-Yen
    Huang, Jee-Fu
    Hsieh, Ming-Yen
    Lin, Zu-Yau
    Chen, Shinn-Cherng
    Hsieh, Ming-Yuh
    Wang, Liang-Yen
    Chuang, Wan-Long
    Yu, Ming-Lung
    HEPATOLOGY INTERNATIONAL, 2010, 4 (04) : 732 - 740
  • [28] Hepatitis G virus infection in chronic hepatitis C: Frequency, features and response to interferon therapy
    Saiz, JC
    Ampurdanes, S
    Olmedo, E
    LopezLabrador, FX
    Forns, X
    Guilera, M
    Tassies, D
    Costa, J
    SanchezTapias, JM
    deAnta, MTJ
    Rodes, J
    JOURNAL OF HEPATOLOGY, 1997, 26 (04) : 787 - 793
  • [29] Adverse effects of interferon-gamma therapy on murine cytomegalovirus infection.
    Pomeroy, C
    Clabots, C
    Riciputi, P
    Filice, G
    CLINICAL INFECTIOUS DISEASES, 1996, 23 (04) : 113 - 113
  • [30] Alpha interferon therapy in chronic hepatitis due to dual infection with hepatitis B and C.
    Guptan, RC
    Thakur, V
    Raina, V
    Sarin, SK
    HEPATOLOGY, 1998, 28 (04) : 218A - 218A